Geron Corp. (GERN) expected to report EPS of -$0.1 for the current quarter

In the latest session, Geron Corp. (NASDAQ: GERN) closed at $3.32 up 3.43% from its previous closing price of $3.21. In other words, the price has increased by $+0.1100 from its previous closing price. On the day, 7925650 shares were traded.

Ratios:

For a deeper understanding of Geron Corp.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.16 and its Current Ratio is at 3.16. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.15.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 15, 2024, Reiterated its Buy rating but revised its target price to $5 from $4 previously.

On September 12, 2023, Goldman Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.

On March 28, 2023, Goldman started tracking the stock assigning a Neutral rating and target price of $3.Goldman initiated its Neutral rating on March 28, 2023, with a $3 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 24 ’23 when O’Farrell Elizabeth G. bought 6,607 shares for $2.28 per share. The transaction valued at 15,064 led to the insider holds 7,407 shares of the business.

O’Farrell Elizabeth G. bought 6,579 shares of GERN for $15,000 on Aug 24 ’23. The Director now owns 26,220 shares after completing the transaction at $2.28 per share. On May 11 ’23, another insider, LAWLIS V BRYAN, who serves as the Director of the company, sold 35,000 shares for $3.00 each. As a result, the insider received 105,000 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 1.95B and an Enterprise Value of 1.70B. For the stock, the TTM Price-to-Sale (P/S) ratio is 8134.83 while its Price-to-Book (P/B) ratio in mrq is 7.30. Its current Enterprise Value per Revenue stands at 7.19k whereas that against EBITDA is -9.75.

Stock Price History:

Over the past 52 weeks, GERN has reached a high of $3.73, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is 2.3930, while the 200-Day Moving Average is calculated to be 2.3535.

Shares Statistics:

For the past three months, GERN has traded an average of 11.49M shares per day and 9.16M over the past ten days. A total of 544.91M shares are outstanding, with a floating share count of 482.08M. Insiders hold about 18.03% of the company’s shares, while institutions hold 51.17% stake in the company. Shares short for GERN as of Mar 15, 2024 were 50.95M with a Short Ratio of 4.43, compared to 43.57M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.33% and a Short% of Float of 9.37%.

Earnings Estimates

There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.1, while EPS last year was -$0.07. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.1 and low estimates of -$0.12.

Analysts are recommending an EPS of between -$0.26 and -$0.39 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.17, with 5 analysts recommending between -$0.01 and -$0.37.

Revenue Estimates

A total of 5 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $99.35M, while the lowest revenue estimate was $8.99M, resulting in an average revenue estimate of $53.07M. In the same quarter a year ago, actual revenue was $237k, up 22,292.40% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $251.33M in the next fiscal year. The high estimate is $386.82M and the low estimate is $39.91M. The average revenue growth estimate for next year is up 373.60% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]